Differences in immune cells predict skin cancer treatment outcomes

In a first-of-its-kind study by King's College London, researchers have linked changes in two major types of immune cells in blood to different survival outcomes for patients with melanoma. Melanoma, the fifth most common cancer in the U.K., is one of the deadliest forms of skin cancer but is highly